Beware ... dangerous drug for heart health

WASHINGTON-called European health authorities to stop the use of diet drugs Abbott Laboratories Inc. outputs. The reason, the drugs were associated with risk of heart attack. Diet drug in question is a trademarked acomplia, Reduxade, and Zelium.

According POM Europe, these drugs contain sibutramin called them: the risks outweigh the benefits. They advised doctors not to recommend the drug to the patient. Meanwhile, the European Commission will soon recommend that all drugs were withdrawn from circulation.

In the United States, drug control authorities and food Food and Drug Administration (FDA) also called for the same thing. According to them, the use of these drugs suspected to increase heart attack and stroke in people with heart problems.

The FDA stated in a written statement Abbott has agreed to their plea to not use these drugs in patients with a history of heart disease. In the near future, they will hold a meeting with a public advisory committee about what the next steps should be taken.